AMENDED AND RESTATED LICENSE AND SERVICES AGREEMENT Between PROTIVA AGRICULTURAL DEVELOPMENT COMPANY INC. on the one hand, and PROTIVA BIOTHERAPEUTICS INC. and ARBUTUS BIOPHARMA CORPORATION, on the other hand Dated: March 4, 2016License and Services Agreement • March 9th, 2016 • Arbutus Biopharma Corp • Pharmaceutical preparations • New York
Contract Type FiledMarch 9th, 2016 Company Industry JurisdictionThis Amended and Restated License and Services Agreement (this “Agreement”) is entered into as of March 4, 2016 (the “Effective Date”), between Protiva Agricultural Development Company Inc., a British Columbia corporation with a principal place of business at 100‑8900 Glenlyon Parkway, Burnaby, B.C., Canada V5J 5J8 (“PadCo”), on the one hand, and Protiva Biotherapeutics, Inc., a British Columbia corporation with a principal place of business at 100‑8900 Glenlyon Parkway, Burnaby, B.C., Canada V5J 5J8 (“Protiva”), and Arbutus Biopharma Corporation (formerly, Tekmira Pharmaceuticals Corporation), a British Columbia corporation with a principal place of business at 100‑8900 Glenlyon Parkway, Burnaby, B.C., Canada V5J 5J8 (“Arbutus”), on the other hand.
Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed...License and Services Agreement • March 28th, 2014 • TEKMIRA PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
Contract Type FiledMarch 28th, 2014 Company Industry JurisdictionThis License and Services Agreement (this “Agreement”) is entered into as of January 12, 2014 (the “Effective Date”), between Protiva Agricultural Development Company Inc., a British Columbia corporation with a principal place of business at 100-8900 Glenlyon Parkway, Burnaby, B.C., Canada V5J 5J8 (“PadCo”), on the one hand, and Protiva Biotherapeutics, Inc., a British Columbia corporation with a principal place of business at 100-8900 Glenlyon Parkway, Burnaby, B.C., Canada V5J 5J8 (“Protiva”), and Tekmira Pharmaceuticals Corporation, a British Columbia corporation with a principal place of business at 100-8900 Glenlyon Parkway, Burnaby, B.C., Canada V5J 5J8 (“Tekmira”), on the other hand.
LICENSE AND SERVICES AGREEMENT Between PROTIVA AGRICULTURAL DEVELOPMENT COMPANY INC. on the one hand, and PROTIVA BIOTHERAPEUTICS INC. and TEKMIRA PHARMACEUTICALS CORPORATION, on the other hand Dated: January 12, 2014License and Services Agreement • January 23rd, 2014 • TEKMIRA PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
Contract Type FiledJanuary 23rd, 2014 Company Industry JurisdictionThis License and Services Agreement (this “Agreement”) is entered into as of January 12, 2014 (the “Effective Date”), between Protiva Agricultural Development Company Inc., a British Columbia corporation with a principal place of business at 100-8900 Glenlyon Parkway, Burnaby, B.C., Canada V5J 5J8 (“PadCo”), on the one hand, and Protiva Biotherapeutics, Inc., a British Columbia corporation with a principal place of business at 100-8900 Glenlyon Parkway, Burnaby, B.C., Canada V5J 5J8 (“Protiva”), and Tekmira Pharmaceuticals Corporation, a British Columbia corporation with a principal place of business at 100-8900 Glenlyon Parkway, Burnaby, B.C., Canada V5J 5J8 (“Tekmira”), on the other hand.